1.
Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus
by Dedrick, Rebekah M
Nature medicine, 2019-05, Vol.25 (5), p.730-733

2.

3.
Whole-genome sequencing to identify transmission of Mycobacterium abscessus between patients with cystic fibrosis: a retrospective cohort study
by Bryant, Josephine M, BSc
The Lancet (British edition), 2013, Vol.381 (9877), p.1551-1560

4.
The lower airway microbiota in early cystic fibrosis lung disease: a longitudinal analysis
by Frayman, Katherine B
Thorax, 2017-12, Vol.72 (12), p.1104-1112

5.
Novel immunologic classification of aspergillosis in adult cystic fibrosis
by Baxter, Caroline G., PhD
Journal of allergy and clinical immunology, 2013, Vol.132 (3), p.560-566.e10

6.
Bolus Weekly Vitamin D3 Supplementation Impacts Gut and Airway Microbiota in Adults With Cystic Fibrosis: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial
by Kanhere, Mansi Mansi
The journal of clinical endocrinology and metabolism, 2017-11-16, Vol.103 (2), p.564-574

7.
Current and future therapies for Pseudomonas aeruginosa infection in patients with cystic fibrosis
by Smith, Wynne D
FEMS microbiology letters, 2017-08-01, Vol.364 (14)

8.
Pseudomonas aeruginosa Biofilms in Disease
by Mulcahy, Lawrence R
Microbial ecology, 2014-07-01, Vol.68 (1), p.1-12

9.
Pseudomonas aeruginosa biofilms in cystic fibrosis
by Høiby, Niels
Future microbiology, 2010-11, Vol.5 (11), p.1663-1674

10.
Sputum microbiota is predictive of long-term clinical outcomes in young adults with cystic fibrosis
by Acosta, Nicole
Thorax, 2018-11, Vol.73 (11), p.1016-1025

11.

12.
Burkholderia cenocepacia in cystic fibrosis: epidemiology and molecular mechanisms of virulence
by Drevinek, P
Clinical microbiology and infection, 2010-07, Vol.16 (7), p.821-830

13.
Relevance of multidrug-resistant Pseudomonas aeruginosa infections in cystic fibrosis
by Stefani, S
International journal of medical microbiology, 2017-09, Vol.307 (6), p.353-362

14.
BACTERIAL BIOFILMS: An Emerging Link to Disease Pathogenesis
by Parsek, Matthew R
Annual review of microbiology, 2003-10, Vol.57 (1), p.677-701

15.
Antimicrobial resistance in the respiratory microbiota of people with cystic fibrosis
by Sherrard, Laura J, PhD
The Lancet (British edition), 2014, Vol.384 (9944), p.703-713

16.
Microbiome in lung explants of idiopathic pulmonary fibrosis: a case–control study in patients with end-stage fibrosis
by Kitsios, Georgios D
Thorax, 2018-05, Vol.73 (5), p.481-484

17.
Cleavage of CXCR1 on neutrophils disables bacterial killing in cystic fibrosis lung disease
by Hartl, Dominik
Nature medicine, 2007, Vol.13 (12), p.1423-1430

18.
Viability of Pseudomonas aeruginosa in cough aerosols generated by persons with cystic fibrosis
by Knibbs, Luke D
Thorax, 2014-08, Vol.69 (8), p.740-745

19.

20.
Intravenous antibiotics reduce the presence of Aspergillus in adult cystic fibrosis sputum
by Baxter, Caroline G
Thorax, 2013-07, Vol.68 (7), p.652-657
